Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma: A Pooled Analysis
新辅助双重免疫检查点抑制剂与抗PD-1疗法治疗高危可切除黑色素瘤：一项汇总分析
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2023.7333
Mangla, Ankit; Lee, Chanmi; Mirsky, Matthew M; Wang, Margaret; Rothermel, Luke D; Hoehn, Richard; Bordeaux, Jeremy S; Carroll, Bryan T; Theuner, Jason; Li, Shawn; Fu, Pingfu; Kirkwood, John M
